Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia

BACKGROUND: Alpha-1 antitrypsin (A1AT) deficiency has been recognized as an adverse prognostic determinant in severe instances of COVID-19. OBJECTIVE: To determine the A1AT phenotypes and levels in individuals at various clinical stages of COVID-19 compared to healthy controls. DESIGN: Case-control...

Full description

Saved in:
Bibliographic Details
Main Authors: Norsyuhadah Musa, Wan Norlina Wan Azman, Nor Amirah Mohammad Nazri, Tuan Salwani Tuan Ismail, Azian Harun, Najib Majdi Yaacob, Sarina Sulong, K.N.S Sirajudeen, Mahaya Che Mat, Hani Ajrina Zulkeflee
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2025-07-01
Series:Annals of Saudi Medicine
Subjects:
COVID-19
Alpha-Antitrypsin
screening
protein
Online Access:http://www.annsaudimed.net/doi/10.5144/0256-4947.2025.225
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.annsaudimed.net/doi/10.5144/0256-4947.2025.225

Similar Items